8-K: My Size, Inc. Reprices Executive Stock Options Amidst Share Price Decline, Accelerates Vesting for Former CFO
Executive Compensation Adjustment
My Size, Inc. announced a significant reduction in the exercise price of executive stock options and accelerated the vesting of restricted shares for its former Chief Financial Officer, reflecting adjustments to compensation arrangements.
Summary
- My Size, Inc.'s Compensation Committee reduced the exercise price of 13,926 outstanding common stock options for certain employees, officers, and directors.
- The exercise prices, which previously ranged from $3.832 to $8.72 per share, were lowered to $1.28 per share, matching the closing price on June 4, 2025.
- Affected executives include CEO Ronen Luzon (800 shares), former CFO Or Kles (650 shares), and CPO/COO Billy Pardo (650 shares).
- The Compensation Committee also accelerated the vesting of 18,750 restricted shares held by former CFO Or Kles, making them fully vested as of his termination date on March 31, 2025, in recognition of his dedicated service.
Sentiment
Score: 3
Explanation: The repricing of executive stock options due to a significant drop in share price is a negative signal, indicating past underperformance. While the acceleration of vesting for a departing executive is a positive for that individual, the overall compensation adjustments reflect challenges in stock performance.
Positives
- Acceleration of restricted share vesting for former CFO Or Kles acknowledges his dedicated service to the company.
Negatives
- The significant reduction in option exercise prices (from a range of $3.832-$8.72 down to $1.28) indicates a substantial decline in the company's stock price, suggesting poor past performance.
- Repricing options can dilute shareholder value and may signal a lack of confidence in the company's near-term stock price recovery.
Future Outlook
NA
Management Comments
- In recognition of Mr. Kless dedicated service to the Company, the Compensation Committee of the Board of Directors of the Company accelerated the vesting of the unvested portion of the 18,750 restricted shares held by Mr. Kles such that as of Mr. Kless termination of service on March 31, 2025, the restricted shares are deemed fully vested.
Industry Context
The repricing of stock options is a common practice in industries where stock prices have experienced significant declines, often used to re-incentivize management and align their interests with potential future stock appreciation. This action by My Size, Inc. suggests the company's stock has faced considerable headwinds, a trend observed in some technology or growth-oriented companies during periods of market volatility or specific company underperformance.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Financial Officer | Or Kles | NA | 2025-03-31 | Termination of service; vesting of restricted shares accelerated in recognition of dedicated service. |
Stakeholder Impact
- Shareholders: Potential dilution from repriced options if exercised, and the repricing itself signals significant past share price depreciation, which negatively impacts existing shareholders.
- Employees/Officers/Directors: Those holding the repriced options benefit from a lower exercise price, re-incentivizing them despite the stock's decline. The former CFO also benefits from accelerated vesting.
Key Dates
| Date | Description |
|---|---|
| 2025-03-31 | Termination of service for Or Kles, former Chief Financial Officer, and effective date for full vesting of his restricted shares. |
| 2025-06-04 | Date of earliest event reported; Compensation Committee reduced option exercise prices to $1.28 per share, which was the closing price for the Company's shares on this date. |
| 2025-06-06 | Date of signing the Form 8-K report. |
Recommendation
holdKeywords
My Size Inc., MYSZ, SEC Filing, 8-K, Stock Options, Executive Compensation, Option Repricing, Restricted Stock Units, Corporate Governance, CEO Compensation, CFO Compensation, Share Price, Nasdaq Capital Market
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.